Top Markets
Coin of the day
Amoéba S.A. Amoéba S.A.

Amoéba S.A.

ALMIB
Rank in Stocks #14084
Amoéba S.A. develops and sells biocidal and fungicide products. It is... Amoéba S.A. develops and sells biocidal and fungicide products. It is developing around multiple applications using the amoeba Willaertia magna C2c Maky in the prevention of microbiological risk for water treatment, human wounds, and plant protection. The company was founded in 2010 and is headquartered in Chassieu, France.
Share Price
$0.87538252
Market Cap
$68.09M
Change (1 day)
-2.64%
Change (1 year)
-19.55%
Country
FR
Trade Amoéba S.A. (ALMIB)
Revenue for Amoéba S.A. (ALMIB)
Revenue in Dec 2025 TTM: 0.00
According to Amoéba S.A. latest financial reports the company's current revenue (TTM) is 0.00. In 2023 the company made a revenue of $734.37K an increase over the revenue in the year 2022 that was 0.00. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Amoéba S.A. from 2012 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) 0.00 -100.00%
2024 $626.00K -14.76%
2023 $734.37K 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
2020 0.00 -100.00%
2019 $137.42K 97,699.86%
2018 $140.51 -27.38%
2017 $193.48 46.00%
2016 $132.52 -13.41%
2015 $153.04 -99.94%
2014 $269.19K -35.23%
2013 $415.59K 286.49%
2012 $107.53K 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$17.89B -
US
$17.89B -
US
$27.83B -
CA
$16.22B -
NO
$542.01M -
CN